CheckMyStock - Developed By GMS Ahimsa
Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO)
$10.65 0.00 (0.00%)
Financial Ratios
Book Value per Share (BVPS)
N/A
Net asset value per share of common stock
Debt-to-Equity Ratio
1.64
(Financial Modeling Prep)
Measures financial leverage and company risk
Return on Invested Capital (ROIC)
7.88%
(Financial Modeling Prep)
Efficiency of capital allocation for generating returns
Price-to-Earnings Ratio (P/E)
42.60
(Financial Modeling Prep (calculated))
Shows how much investors are willing to pay per dollar of earnings
Company Information
Company Name
Taiwan Advance Bio-Pharmaceutical Inc.
Stock Ticker
4186.TWO
Market Cap
N/A
52 Week Range
9.93-17.65
Price
$10.65
Dividend Yield
N/A
About Taiwan Advance Bio-Pharmaceutical Inc.
Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. The company provides food safety diagnostic testing kits; ELISA, rapid, and chemical test kits customization, and food safety lab establishment consultation services; and manufactures monoclonal and polyclonal antibody products. It also offers abused drugs rapid tests; provides cell banking services for newborn and adult stem cells storage; and operates drug testing center for urine drug test, hair drug test, and identification of drug abuse. The company was founded in 1989 and is based in New Taipei City, Taiwan.